Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-07-31
1981-01-27
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 15, 424 9, 128654, A61K 4900, A61K 4300, G01T 100
Patent
active
042475341
ABSTRACT:
A composition and method for the preparation of a technetium-99m-based scanning agent are disclosed. The scanning agent is prepared from .sup.99m Tc, in a +3, +4 and/or +5 oxidation state, and a methanehydroxydiphosphonate bone-seeking agent which carries the radionuclide to bone mineral. The methanehydroxydiphosphonate agent provides scan sharpness equivalent or superior to commercial scanning agents, and is superior for detecting myocardial infarcts, as compared with commercial scanning agents such as ethane-1-hydroxy-1,1-diphosphonate and methanediphosphonate.
REFERENCES:
patent: 3983227 (1976-09-01), Tofe et al.
Goldstein Steven J.
Nucker Christine M.
Padgett Benjamin R.
Roth Michael J.
The Procter & Gamble & Company
LandOfFree
Radiographic scanning agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiographic scanning agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiographic scanning agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1181655